{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:06:42Z","timestamp":1783649202799,"version":"3.55.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.lungcan.2014.06.003","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T21:40:19Z","timestamp":1402954819000},"page":"481-484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Efficacy and safety of gefitinib during pregnancy: Case report and literature review"],"prefix":"10.1016","volume":"85","author":[{"given":"S.","family":"Gil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Goetgheluck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Paci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Broutin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Friard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.J.","family":"Couderc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Ayoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Picone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5251-5434","authenticated-orcid":false,"given":"C.","family":"Tcherakian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 6","key":"10.1016\/j.lungcan.2014.06.003_bib0005","doi-asserted-by":"crossref","first-page":"vi160","DOI":"10.1093\/annonc\/mdt199","article-title":"Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Peccatori","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lungcan.2014.06.003_bib0010","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.lungcan.2013.09.002","article-title":"Lung cancer in pregnancy: report of nine cases from an international collaborative study","volume":"82","author":"Boussios","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2014.06.003_bib0015","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ctrv.2014.03.006","article-title":"Beyond EGFR TKI in EGFR-mutant non-small cell lung cancer patients: main challenges still to be overcome","volume":"40","author":"Remon","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.lungcan.2014.06.003_bib0020","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1200\/JCO.2009.23.2801","article-title":"Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes","volume":"28","author":"Van Calsteren","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2014.06.003_bib0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ctrv.2009.11.007","article-title":"Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: solid tumors","volume":"36","author":"Azim","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.lungcan.2014.06.003_bib0030","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1378\/chest.128.1.370","article-title":"Lung cancer in women: emerging differences in epidemiology, biology, and therapy","volume":"128","author":"Thomas","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.lungcan.2014.06.003_bib0035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/376337a0","article-title":"Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor","volume":"376","author":"Miettinen","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2014.06.003_bib0040","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.lungcan.2012.03.026","article-title":"Use of erlotinib throughout pregnancy: a case-report of a patient with metastatic lung adenocarcinoma","volume":"77","author":"Rivas","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2014.06.003_bib0045","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.lungcan.2007.10.025","article-title":"Erlotinib administration for advanced non-small cell lung cancer during the first 2 months of unrecognized pregnancy","volume":"60","author":"Zambelli","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2014.06.003_bib0050","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.lungcan.2011.08.008","article-title":"Successful pregnancy with epidermal growth factor receptor tyrosine kinase inhibitor treatment of metastatic lung adenocarcinoma presenting with respiratory failure","volume":"74","author":"Lee","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2014.06.003_bib0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ctrv.2010.08.006","article-title":"Moving towards dose individualization of tyrosine kinase inhibitors","volume":"37","author":"Kl\u00fcmpen","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.lungcan.2014.06.003_bib0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2710.2004.00543.x","article-title":"Gefitinib, a novel, orally administered agent for the treatment of cancer","volume":"29","author":"Ranson","year":"2004","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.lungcan.2014.06.003_bib0065","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1158\/1535-7163.MCT-12-0880","article-title":"Quantitative chemical proteomics profiling differentiates erlotinib from gefitinib in EGFR wild-type non-small cell lung carcinoma cell lines","volume":"12","author":"Augustin","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.lungcan.2014.06.003_bib0070","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/CAD.0b013e32833034e1","article-title":"Epidermal growth factor receptor tyrosine kinase inhibitors: similar but different?","volume":"20","author":"Rukazenkov","year":"2009","journal-title":"Anticancer Drugs"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950021400261X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950021400261X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T01:25:05Z","timestamp":1597973105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016950021400261X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S016950021400261X"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2014.06.003","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of gefitinib during pregnancy: Case report and literature review","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2014.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}